Suppr超能文献

用于大肠杆菌中重组蛋白表达的先进遗传策略。

Advanced genetic strategies for recombinant protein expression in Escherichia coli.

作者信息

Sørensen Hans Peter, Mortensen Kim Kusk

机构信息

Laboratory of BioDesign, Department of Molecular Biology, Aarhus University, Gustav Wieds Vej 10 C, DK-8000 Aarhus C, Denmark.

出版信息

J Biotechnol. 2005 Jan 26;115(2):113-28. doi: 10.1016/j.jbiotec.2004.08.004.

Abstract

Preparations enriched by a specific protein are rarely easily obtained from natural host cells. Hence, recombinant protein production is frequently the sole applicable procedure. The ribosomal machinery, located in the cytoplasm is an outstanding catalyst of recombinant protein biosynthesis. Escherichia coli facilitates protein expression by its relative simplicity, its inexpensive and fast high-density cultivation, the well-known genetics and the large number of compatible tools available for biotechnology. Especially the variety of available plasmids, recombinant fusion partners and mutant strains have advanced the possibilities with E. coli. Although often simple for soluble proteins, major obstacles are encountered in the expression of many heterologous proteins and proteins lacking relevant interaction partners in the E. coli cytoplasm. Here we review the current most important strategies for recombinant expression in E. coli. Issues addressed include expression systems in general, selection of host strain, mRNA stability, codon bias, inclusion body formation and prevention, fusion protein technology and site-specific proteolysis, compartment directed secretion and finally co-overexpression technology. The macromolecular background for a variety of obstacles and genetic state-of-the-art solutions are presented.

摘要

富含特定蛋白质的制剂很难从天然宿主细胞中轻易获得。因此,重组蛋白生产常常是唯一可行的方法。位于细胞质中的核糖体机制是重组蛋白生物合成的杰出催化剂。大肠杆菌因其相对简单、廉价且快速的高密度培养、广为人知的遗传学以及大量适用于生物技术的兼容工具,便于蛋白质表达。特别是各种可用的质粒、重组融合伙伴和突变菌株拓展了利用大肠杆菌的可能性。尽管对于可溶性蛋白质来说通常较为简单,但在大肠杆菌细胞质中表达许多异源蛋白质以及缺乏相关相互作用伙伴的蛋白质时,会遇到主要障碍。在此,我们综述了目前在大肠杆菌中进行重组表达的最重要策略。涉及的问题包括一般的表达系统、宿主菌株的选择、mRNA稳定性、密码子偏好、包涵体形成及预防、融合蛋白技术和位点特异性蛋白酶解、隔室定向分泌以及最后的共过表达技术。文中介绍了各种障碍的大分子背景以及最新的遗传解决方案。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验